Navigation Links
Elan-EC

ProductsElan-EC
Company AESCULAP
Item Elan-EC
Features 
  • rated one of the most reliable systems by surgeons worldwide for over 30 years
  • powerful, high torque, low speed system
  • automatically recognizes and corrects speed deceleration under load
  • comprehensive range of handpieces, compatible with HiLAN XS and Microspeed EC systems
  • complete line of burrs and blades
    • Description The workhorse electric system.
    Info AESCULAP
    Customer Service: (800) 282-9000
    Web site: http://www.aesculapusa.com/

    Related medicine products :

    1. BD™ Safety Knife with BD Xstar™ Blade 2.50 mm
    2. BD™ Safety Knife with BD Xstar™ Blade 2.60 mm
    3. BD™ Safety Knife with BD Xstar™ Blade 2.75 mm
    4. BD™ Safety Knife with BD Xstar™ Blade 3.00 mm
    5. Safety Lock Rib-Back
    6. Bunnell Mini-Modified Safety Finger Pin
    7. Class II Type A2 Biological Safety Cabinet
    8. Class II Type B1 Biological Safety Cabinet
    9. Calss II Type B2 Biological Safety Cabinet
    10. Class II Type B2 Biological Safety Cabinet
    11. Fixed Core Straight Safety Wire Guides - Standard (stainless steel)
    TAG: Elan
    Other Medicine News:Health News:Reed Smith to Merge with Richards Butler Hong Kong 2Health News:Reed Smith to Merge with Richards Butler Hong Kong 3Health News:Reed Smith to Merge with Richards Butler Hong Kong 4Health News:The politics of the playground: lack of athletic skill often means loneliness and peer rejection 2Health News:MDS Nordion signs 17-year contract with Rosenergoatom 2Health News:UP Repeats NCQA Certification in Utilization Management 2Health News:Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock 2Health News:Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock 3Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 2Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 3Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 4Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 5Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 6Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 7Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 8Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 9Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 10Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 11Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 12Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 13Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 14
    Breaking Medicine Technology:Within3 Expands into Mobile Applications 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Tim McGraw and Faith Hill Join Senior Military for Country United 3A Advancing Medicine From the Frontlines to the Homefront 47536 1Tim McGraw and Faith Hill Join Senior Military for Country United 3A Advancing Medicine From the Frontlines to the Homefront 47536 2Tim McGraw and Faith Hill Join Senior Military for Country United 3A Advancing Medicine From the Frontlines to the Homefront 47536 3New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 47533 1New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 47533 2New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 47533 3Viewers Beware Report by Watchdog Group Exposes Conservative Group Behind Anti Healthcare Ads Running in Montana 47530 1Viewers Beware Report by Watchdog Group Exposes Conservative Group Behind Anti Healthcare Ads Running in Montana 47530 2